Drug Farm Announces FDA Fast Track Designation for First-in-Class ALPK1 Inhibitor DF-003 for the Treatment of ROSAH Syndrome

DF-003 is the first ALPK1 inhibitor to successfully complete a first-in-human Phase 1 study and has now entered a Phase 1b clinical trial in patients with ROSAH syndrome (NCT06395285), where it is ...
Seeking Alpha

INTI Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United ...
Seeking Alpha

WD-40: The Valuation Rests Like Rust On The Stock - Sell

WD-40 Company is rated a sell due to persistent overvaluation and stagnant cash flow growth despite solid sales performance. WDFC trades above 30x FCF, with operating cash flow and free cash flow ...